Uses of an alkoxy-substituted phenyl compound, methods for promoting symbiotic germination of medicinal orchid seeds and fungal propagation

By using alkoxy-substituted phenyl compounds as promoters during the symbiotic germination of medicinal orchid seeds, the problems of poor efficacy and poor compatibility in existing technologies have been solved, resulting in a significant increase in mycelial biomass and seed symbiotic germination rate, making it suitable for industrial application.

CN123100631APending Publication Date: 2026-11-17INST OF MEDICINAL PLANT DEV CHINESE ACADEMY OF MEDICAL SCI
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202611294742.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-08-25
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

Existing technologies for promoting the symbiotic germination of medicinal orchid seeds have limited effectiveness and poor adaptability. Traditional signaling molecules cannot effectively enhance mycelial proliferation and seed symbiotic germination rates, and there is a lack of operable technical solutions suitable for industrial seedling cultivation.

Method used

Alkoxylated phenyl compounds, such as 4-methoxybenzoyl glucoside and p-methoxybenzoic acid, are used as promoters, which have both chemical induction and nutrient supply functions. By adding these compounds to the culture system, the chemotaxis of symbiotic fungi is promoted and carbon sources are provided, thereby improving mycelial growth and seed symbiotic germination rate.

Benefits of technology

It significantly increases mycelial biomass by more than 32% and seed symbiotic germination rate by more than 10%, and is effective in a very low concentration range, reducing application costs. It is suitable for a variety of medicinal orchid plants, is easy to operate and can be applied on a large scale, and is environmentally friendly.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123100631A_ABST
    Figure CN123100631A_ABST
Patent Text Reader

Abstract

This invention discloses the use of alkoxy-substituted phenyl compounds and a method for promoting the symbiotic germination of medicinal orchid seeds and the propagation of fungi, belonging to the field of plant cultivation and microbial technology. The technical solution of this invention includes applying a phenolic acid compound with a specific structure, specifically 4-methoxybenzoyl glucoside or p-methoxybenzoic acid, to prepare a promoter for the symbiotic germination of medicinal orchid seeds. Alternatively, the above-mentioned phenolic acid compound is applied to a culture system containing orchid seeds and symbiotic fungi at a final concentration of 0.001~10 μm. This phenolic acid compound not only induces chemotaxis in the symbiotic fungi but also serves as a carbon source for fungal metabolism, thereby synergistically promoting mycelial growth and symbiotic germination. This invention improves the symbiotic germination efficiency of medicinal orchids by providing a promoter with both signal recognition and nutrient supply functions, and has significant industrial application value.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the fields of plant cultivation and microbial technology, and in particular to the use of an alkoxy-substituted phenyl compound and a method for promoting the symbiotic germination of medicinal orchid seeds and the propagation of fungi. Background Technology

[0002] Medicinal orchids, such as Rhododendron, Dendrobium, and Bletilla striata, possess extremely high medicinal and economic value. However, the seeds of these plants are tiny and lack endosperm. Under natural conditions, they must combine with specific symbiotic fungi to obtain carbon and nutrients to complete symbiotic germination. Therefore, the large-scale artificial propagation of medicinal orchids usually relies on simulating their symbiotic germination process, and how to efficiently promote the interaction between seeds and symbiotic fungi is a key step.

[0003] Currently, to improve symbiotic germination efficiency, researchers are attempting to add exogenous active substances to the culture system. A common technique involves using signaling molecules secreted by plant roots, such as strigolactones or flavonoids, to induce symbiotic fungi to approach the plant. However, the main mechanisms of action for these substances are chemical recognition and chemotactic induction; they themselves cannot be decomposed and utilized by the symbiotic fungi as nutrients. Therefore, in practical applications, they can only slightly enhance the directional migration ability of hyphae, but cannot sustainably promote hyphal biomass accumulation, resulting in limited improvement in seed symbiotic germination rates. Furthermore, their compatibility with microseed systems of medicinal orchids is poor.

[0004] Another type of related research focuses on the metabolic mechanisms of phenolic acids by microorganisms. For example, some studies have explored the intracellular metabolic pathways of phenolic acid degradation by fungi by adding phenolic acids to fungal cultures. However, such studies mostly remain at the level of basic mechanisms, aiming to reveal biological processes, but completely neglecting the application of phenolic acids in the propagation of medicinal orchids. Furthermore, they lack operable technical solutions for industrial-scale seedling production, such as application concentrations, methods, and promoter formulations, and cannot directly solve the practical problems of large-scale seedling production of medicinal orchids. In addition, while research on the interaction mechanisms between medicinal orchids and symbiotic fungi has made some progress, most studies focus on the later carbon exchange process after mycelial invasion of seeds to form fungal colonies, or only observe at the omics level that seed secretions can be sensed by fungi, without isolating and identifying specific active monomers and verifying their application effects.

[0005] In summary, existing technologies for regulating mycorrhizal symbiosis primarily utilize exogenous signaling molecules with only recognition functions, lacking endogenous promoters that can simultaneously serve as chemotactic signals and nutrient carbon sources, and are naturally adapted to the seed systems of medicinal orchids. Therefore, current methods generally suffer from drawbacks such as slow mycelial proliferation, limited improvement in seed germination rates, and poor batch-to-batch stability of seedlings. There is an urgent need to develop a new technology to improve the symbiotic germination efficiency of medicinal orchids. Summary of the Invention

[0006] To address the limitations and poor adaptability of existing methods for promoting the symbiotic germination of medicinal orchids, this invention provides a method for using alkoxy-substituted phenyl compounds to promote the symbiotic germination of medicinal orchid seeds and for fungal propagation. The specific compound used in this invention possesses both chemical induction and nutrient supply functions, significantly promoting the growth of symbiotic fungi and increasing the symbiotic germination rate of medicinal orchid seeds.

[0007] This invention provides, in one aspect, the use of alkoxy-substituted phenyl compounds, wherein the compounds are selected from:

[0008] Compounds having the structure shown in Formula I or an agriculturally acceptable salt thereof, wherein Formula I is Ar-CO-O-R2, Ar is a phenyl substituted with one or more C1-C4 alkoxy groups, and R2 is a monosaccharide residue;

[0009] And compounds having the structure shown in Formula II or agriculturally acceptable salts thereof, wherein Formula II is Ar-COOH, and Ar is a phenyl group substituted with one or more C1-C4 alkoxy groups. This application utilizes the fact that the compounds not only act as signaling molecules to induce chemotaxis in symbiotic fungi, but can also be degraded by fungi as a carbon source, thereby synergistically promoting mycelial growth and seed symbiotic germination.

[0010] In one embodiment, the compound is 4-methoxybenzoyl glucoside.

[0011] In another embodiment, the compound is p-methoxybenzoic acid.

[0012] Optionally, the symbiotic fungus is selected from one or more of the genera *Coprinus*, *Morchella*, and *Rhizoctonia*. These fungi are typical symbiotic fungi of medicinal orchids and have good synergistic effects with the compounds provided by this invention.

[0013] Optionally, the medicinal orchid is selected from one or more of the following: Rhododendron, Ginseng, Bletilla striata, Dendrobium, and Jade Phoenix. These are all medicinal orchids whose seed germination heavily depends on symbiotic fungi, making them ideal targets for the application of the technology of this invention.

[0014] Another aspect of the present invention provides a method for promoting the symbiotic germination of medicinal orchid seeds, comprising the steps of: applying one or more compounds to a culture system containing the medicinal orchid seeds and the symbiotic fungus no later than inoculation of the symbiotic fungus; wherein the one or more compounds are selected from: compounds having the structure shown in Formula I or an agriculturally acceptable salt thereof, wherein Formula I is Ar-CO-O-R2, Ar is a phenyl substituted with one or more C1-C4 alkoxy groups, and R2 is a monosaccharide residue; and compounds having the structure shown in Formula II or an agriculturally acceptable salt thereof, wherein Formula II is Ar-COOH, Ar is a phenyl substituted with one or more C1-C4 alkoxy groups.

[0015] Furthermore, the final concentration of the compound in the culture system is 0.001~10 μm. This concentration range is the effective range of action discovered in this invention, which can achieve significant promoting effects at extremely low concentrations while avoiding the inhibitory effects that may be caused by high concentrations, thus balancing effectiveness and economy.

[0016] Preferably, the compound is 4-methoxybenzoyl glucoside, and its final concentration is 1 μm; or, the compound is p-methoxybenzoic acid, and its final concentration is 0.1 μm. At this optimal concentration, the compound's promoting effect on the growth of symbiotic fungi and seed symbiotic germination reaches its peak.

[0017] In one embodiment, the application step specifically includes: before sowing the medicinal orchid seeds and inoculating the symbiotic fungus, pre-adding and uniformly dissolving the compound in the culture medium constituting the culture system. This application method ensures that the compound is uniformly distributed in the culture medium, providing a uniform growth environment for the subsequent seeds and fungi, which is beneficial for achieving a stable and repeatable promoting effect.

[0018] This invention also provides a method for fungal propagation, comprising the step of culturing the symbiotic fungi in a liquid culture medium supplemented with a compound as an exogenous carbon source; wherein the compound is selected from: compounds having the structure shown in Formula I or agriculturally acceptable salts thereof, wherein Formula I is Ar-CO-O-R2, Ar is a phenyl group substituted with one or more C1-C4 alkoxy groups, and R2 is a monosaccharide residue; and compounds having the structure shown in Formula II or agriculturally acceptable salts thereof, wherein Formula II is Ar-COOH, Ar is a phenyl group substituted with one or more C1-C4 alkoxy groups; and the final concentration of the compound in the liquid culture medium is 0.001~10 μm. This method utilizes the property that the compound can be directly metabolized by fungi, using it as a highly efficient carbon source for the in vitro propagation of fungi, which can effectively increase mycelial biomass and provide high-quality strains for the preparation of inoculum or subsequent inoculation.

[0019] Compared with the prior art, the present invention has the following beneficial effects:

[0020] 1. Dual Function, Significant Effect: The phenolic acid compound used in this invention possesses the dual functions of chemical induction and carbon source nutrition. It not only acts as a signaling molecule to attract symbiotic fungi to grow directionally towards the seeds of medicinal orchids, but it can also be gradually degraded by the fungi and enter the tricarboxylic acid cycle, providing energy for mycelial growth. Compared to traditional signaling molecules with only a single recognition function, this invention can more effectively promote mycelial biomass accumulation and seed symbiotic germination, increasing mycelial fresh weight by more than 32% and seed symbiotic germination rate by more than 10%.

[0021] 2. Low concentration and controllable cost: The compounds used in this invention can exert a significant promoting effect in an extremely low concentration range of 0.001~10μm, which effectively reduces the application cost and avoids the inhibitory effect that may be produced by high concentrations of phenolic acid substances, and has great potential for industrial application.

[0022] 3. Good biocompatibility, safe and environmentally friendly: The 4-methoxybenzoyl glucoside and p-methoxybenzoic acid selected in this invention are both endogenous metabolites naturally secreted from the seeds of medicinal orchid plants. They have excellent biocompatibility and will not produce exogenous chemical residues when applied to the seedling system, making them environmentally friendly.

[0023] 4. Wide range of applications and simple operation: The methods and parameters provided by this invention are applicable to a variety of medicinal orchid plants and their symbiotic fungi, and the operation process is standardized, making it easy to promote and apply in large-scale seedling production. Attached Figure Description

[0024] To more clearly illustrate the technical solutions in the embodiments of the present invention or the prior art, the drawings used in the description of the embodiments or the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For those skilled in the art, other drawings can be obtained based on these drawings without creative effort.

[0025] Figure 1 The ¹H-NMR spectrum of 4-methoxybenzoyl glucoside is shown.

[0026] Figure 2 This is a high-resolution mass spectrum of 4-methoxybenzoyl glucoside.

[0027] Figure 3 This is the ¹H-NMR spectrum of p-methoxybenzoic acid (PMBA).

[0028] Figure 4 This is a high-resolution mass spectrum of p-methoxybenzoic acid (PMBA).

[0029] Figure 5 Statistical graph showing the effects of different concentrations of 4-methoxybenzoyl glucoside and p-methoxybenzoic acid on the growth of symbiotic fungi and the symbiotic germination of Rhododendron simsii.

[0030] Figure 6 This is an HPLC chromatogram showing the time-series transformation of 4-methoxybenzoyl glucoside during co-culture with symbiotic fungi.

[0031] Figure 7 This is a schematic diagram illustrating the mechanism of action of the phenolic acid compounds involved in this invention during the symbiotic germination process of orchids. Detailed Implementation

[0032] To make the objectives, technical solutions, and advantages of this invention clearer, the technical solutions of this invention will be described in detail below. Obviously, the described embodiments are merely some embodiments of this invention, and not all embodiments. Based on the embodiments of this invention, all other embodiments obtained by those skilled in the art without creative effort are within the scope of protection of this invention.

[0033] This invention provides a technical solution for promoting the symbiotic germination of medicinal orchids using specific phenolic acid compounds. In some embodiments, the "promoter" referred to in this invention is a preparation used to promote the symbiotic germination between medicinal orchid seeds and symbiotic fungi, the core active ingredient of which is the specific phenolic acid compound defined in this invention. "Medicinal orchids" refers to a class of orchids with medicinal value, typically terrestrial orchids without endosperm, whose seeds are tiny and require a relationship with symbiotic fungi to germinate symbiotically under natural conditions. "Symbiotic fungi" refers to fungi capable of forming a symbiotic relationship with medicinal orchids to promote their seed symbiotic germination. "Symbiotic germination" refers to the symbiotic germination process of medicinal orchid seeds developing from seed to protocorm with the assistance of symbiotic fungi. The "culture system" refers to the overall environment containing medicinal orchid seeds, symbiotic fungi, and the culture medium used for their growth.

[0034] The core innovation of this invention lies in the fact that the specific phenolic acid compound used possesses the dual functions of "chemotaxis induction" and "carbon source nutrient supply." For example... Figure 7As shown, these compounds not only act as signaling molecules, effectively attracting symbiotic fungi to migrate directionally to the seeds of medicinal orchids, but also undergo gradual decomposition under the action of symbiotic fungi. Their degradation products can directly enter the fungal tricarboxylic acid cycle, providing the necessary carbon source and energy for fungal growth and reproduction. This dual-action mechanism contrasts sharply with existing signaling molecules (such as flavonoids and strigolactones) that possess only a single chemical recognition function. The latter cannot be metabolized by fungi to provide carbon, resulting in slow mycelial proliferation and limited promotion of seed symbiotic germination. The present invention, by providing nutritional support, increases mycelial biomass and seed symbiotic germination rate, solving the problems of poor effectiveness and poor adaptability of traditional methods.

[0035] In one aspect of the invention, the use of a compound in the preparation of a promoter for promoting the symbiotic germination of medicinal orchid seeds is provided. The compound is selected from compounds having the structure shown in Formula I or agriculturally acceptable salts thereof, and compounds having the structure shown in Formula II or agriculturally acceptable salts thereof. Wherein, Formula I is Ar-CO-O-R2, where Ar is a phenyl group substituted with one or more C1-C4 alkoxy groups, and R2 is a monosaccharide residue; Formula II is Ar-COOH, where Ar is a phenyl group substituted with one or more C1-C4 alkoxy groups. These compounds, as the core component of the promoter, can effectively induce chemotaxis of symbiotic fungi towards medicinal orchid seeds and provide a carbon source for the fungi, thereby improving the efficiency of symbiotic germination.

[0036] In a preferred embodiment, the compound of formula I is 4-methoxybenzoyl glucoside. The molecular formula of this compound is C1. 14 H 18 O9, with a precise molecular weight of 360.0974, has a structure consisting of para-methoxybenzoic acid and glucose linked by an ester bond. This compound is an endogenous substance naturally secreted by the seeds of certain medicinal orchid plants. It exhibits excellent biocompatibility, does not produce toxic side effects on seeds or fungi during application, and demonstrates excellent activity as a promoter.

[0037] In another preferred embodiment, the compound of Formula II is p-methoxybenzoic acid. This compound has the molecular formula C8H8O3, a precise molecular weight of 152.0477, and a structure in which a methoxy group and a carboxyl group are connected at the para-position of a benzene ring. p-Methoxybenzoic acid not only possesses excellent symbiotic germination-promoting activity itself, but it is also a first-order degradation product of 4-methoxybenzoyl glucoside under the action of symbiotic fungi. Its application can also efficiently initiate chemotaxis and nutrient supply processes.

[0038] Furthermore, the promoters described in this invention are applicable to a wide range of symbiotic fungi, including but not limited to one or more selected from the genera *Coprinellus disseminatus*, *Tulasnella*, and *Ceratobasidium*. These fungi are natural symbiotic partners of many medicinal orchid plants, and the compounds of this invention can effectively promote their early interactions with the host plant.

[0039] Accordingly, the medicinal orchids to which the promoter described in this invention is applicable also cover several important species, including but not limited to one or more selected from Cremastra appendiculata, Gymnadenia conopsea, Bletilla striata, Dendrobium, and Habenaria. These plants are mostly rare or endangered species, and their artificial propagation is a key bottleneck in the industry's development. The application of this invention provides an effective technical means to solve this bottleneck.

[0040] In another aspect of the invention, a method for promoting the symbiotic germination of medicinal orchid seeds is provided. The method includes the key step of applying one or more of the above-defined compounds (i.e., compounds of formula I or II or their salts) to a culture system containing the medicinal orchid seeds and the symbiotic fungus no later than inoculation with the symbiotic fungus. By introducing these active compounds at the initial stage of establishing the symbiotic relationship, their chemotactic induction effect can be maximized, laying a good foundation for subsequent hyphal infection and nutrient exchange.

[0041] Building upon the aforementioned method, a key technical parameter lies in the application concentration of the compound. Preferably, the final concentration of the compound in the culture system is 0.001–10 μm. Through extensive experiments, the inventors discovered that within this concentration range, the compound's promoting effect is most significant, without inhibiting fungal growth or seed symbiotic germination due to excessively high concentrations. This precise low-concentration application range not only ensures the technical effectiveness but also greatly reduces application costs, making it feasible for large-scale industrial application.

[0042] In a particularly preferred embodiment, when the compound is 4-methoxybenzoyl glucoside, its optimal final concentration in the culture system is 1 μm; and when the compound is p-methoxybenzoic acid, its optimal final concentration is 0.1 μm. At these two optimal concentration points, the compound's effect on increasing mycelial biomass and seed symbiotic germination rate reaches its peak, achieving optimal input-output ratio.

[0043] In one specific implementation, the application step specifically includes: pre-adding and uniformly dissolving the compound in the culture medium constituting the culture system before sowing the medicinal orchid seeds and inoculating the symbiotic fungus. This "pre-addition" timing is crucial, ensuring uniform distribution of the compound throughout the culture medium. When the fungus is inoculated into the culture system, it immediately senses the ubiquitous chemical signal gradient and is strongly and directionally attracted to the vicinity of the seeds, significantly shortening the time between fungal and seed encounter and improving the success rate of symbiosis establishment.

[0044] In another aspect, the present invention provides a method for fungal propagation. This method includes culturing the symbiotic fungi under suitable conditions in a liquid culture medium supplemented with the compound of the present invention as an exogenous carbon source; wherein the compound is also selected from compounds of formula I or II or their salts, and its final concentration in the liquid culture medium is preferably 0.001~10 μm. The suitable conditions include, for example, cultivation at 25°C, in the dark, on a shaker. This method utilizes the characteristic that the compound of the present invention can be decomposed and utilized by fungi as a carbon source, providing a new and efficient cultivation scheme for the industrial production of symbiotic fungal agents, enabling the acquisition of strains with larger biomass and stronger activity. To verify the feasibility of this method and further elucidate the mechanism by which the above-mentioned compound promotes symbiotic germination, subsequent mechanism verification experiments were conducted.

[0045] To more clearly illustrate the technical solution of the present invention, a detailed description is provided below in conjunction with specific embodiments. It should be noted that the experimental instruments and equipment used in the following embodiments include: a Heracell 150i constant temperature dark incubator, a Mettler Toledo electronic analytical balance, a ZHJH-C1106B ultra-clean workbench, a Millipore F7JN55901 pure water system, a Shimadzu LC-6AD semi-preparative liquid chromatograph, an Agilent 1200 high-performance liquid chromatograph, a Buchi Heating Both B490 rotary evaporator, a TG16-WS high-speed centrifuge, an SHZ-D(Ⅲ) circulating water vacuum pump, a KQ3200DE CNC ultrasonic cleaner, a Waters Synapt G UPLC-Q-TOF-ESI-MS / MS mass spectrometer, and Bruker AM500 and AM600 nuclear magnetic resonance spectrometers.

[0046] To conduct subsequent experiments, the two core phenolic acid compounds were first prepared and identified. Specifically, the preparation process of 4-methoxybenzoyl glucoside was as follows: 9g of total methanol extract from Rhododendron seeds was loaded onto an ODS column, and a gradient elution of 10% to 100% was performed using methanol-water solution. Six fractions, Fr.1 to Fr.6, were collected. Fraction Fr.3 (270mg) was collected and further separated using semi-preparative high-performance liquid chromatography (HPLC). The column used was YMCODS-A (250×10mm, 5μm), the mobile phase was 14% acetonitrile-water solution, and the elution time was 20min. The eluent with a retention time of 17.7min was collected, concentrated under reduced pressure, and dried to obtain 34mg of white powdered 4-methoxybenzoyl glucoside, with a purity of not less than 95%.

[0047] The structure of the white powder obtained above was identified. Figure 1 As shown, the ¹H-NMR (500MHz) spectrum measured in DMSO-d6 solvent shows that δ7.90 (m, 2H) and δ7.12 (m, 2H) are hydrogen signals on the benzene ring, δ3.47 (s, 3H) is the hydrogen signal of the para-methoxy group on the benzene ring, and the series of multiplets in the δ3.18–5.37 region correspond to the hydroxyl and methine hydrogens on the glucose ring. Figure 2 As shown, its high-resolution mass spectrometry (HR-ESI-MS) detected the characteristic ion [M-HCOO]⁻ at m / z 359.0974 in negative ion mode, based on which the theoretical molecular formula was determined to be C. 14 H 18 O9, with a precise molecular weight of 360.0974. Furthermore, a fragment ion with an m / z of 151.0404, resulting from the loss of glucose residues, was observed in the mass spectrum. This fragment perfectly matched the mass spectrum signal of p-methoxybenzoic acid, thus confirming the structure of the compound as 4-methoxybenzoyl glucoside.

[0048] Similarly, p-methoxybenzoic acid was also separated and purified by chromatography. 820 mg of the Fr.4 fraction obtained by ODS column chromatography was first separated into three subfractions by gel filtration chromatography. The Fr.4.2 subfraction was then purified by normal-phase silica gel column chromatography using a petroleum ether-acetone system. After drying, 230 mg of white crystalline p-methoxybenzoic acid was obtained, with a purity of not less than 98%.

[0049] The structure of the white crystal was determined. Figure 3As shown, the ¹H-NMR (500MHz) spectrum measured in Acetone-d6 solvent shows that: δ9.21 (s, 1H) is a carboxyl hydrogen, δ7.88 (m, 2H) is a hydrogen adjacent to the carboxyl group on the benzene ring, δ6.91 (m, 2H) is a hydrogen adjacent to the methoxy group on the benzene ring, and δ3.82 (s, 3H) is a hydrogen of the methoxy group. Figure 4 As shown, high-resolution mass spectrometry (HR-ESI-MS) in negative ion mode detected the characteristic ion [MH]⁻ at m / z 151.0404, thus determining the theoretical molecular formula to be C8H8O3 and the precise molecular weight to be 152.0477. Simultaneously, the observed fragment ions at m / z 136.0142 and 92.0254 also conform to the standard fragmentation pathway of p-methoxybenzoic acid. These spectral data collectively confirm that the obtained compound is indeed p-methoxybenzoic acid.

[0050] To verify the actual effect of the prepared 4-methoxybenzoyl glucoside, a series of experiments were conducted to induce fungal chemotaxis and promote the symbiotic germination of *Cremastra appendiculata* seeds. The biological materials used included: mature *Cremastra appendiculata* pods purchased from Chishui Shouhu Dendrobium Planting Co., Ltd.; seeds were collected by peeling in a sterile operating table, disinfected with 75% ethanol for 30 seconds, soaked in 0.1% mercuric chloride for 5 minutes, rinsed 5 times with sterile water, and then sealed at 4℃ in the dark for later use; the symbiotic fungus *Coprinellus disseminatus* strain was provided by Chongqing Institute of Medicinal Plant Cultivation, activated on water agar slant at 25℃ in the dark for 7 days, and fresh mycelial blocks with a diameter of 5 mm were used as inoculum; the basal culture medium was water agar medium with a formula of 6 g agar per liter of ultrapure water, sterilized by autoclaving at 121℃ for 20 minutes before use.

[0051] The experimental steps are as follows: First, the drug solutions were prepared. Purified 4-methoxybenzoyl glucoside was accurately weighed and dissolved thoroughly in sterile DMSO. Then, it was serially diluted with sterile water to prepare five concentration gradients: 0.001, 0.01, 0.1, 1, and 10 μm. A control group with an equal volume of pure DMSO was also included. Next, plate plating was performed. The drug solutions of each concentration were added to sterilized water agar medium cooled to approximately 50°C, thoroughly mixed, and poured into 90 mm diameter petri dishes, allowing them to solidify. An equal amount of *Azalea* seeds were evenly scattered on each plate, and the plates were left to stand for 30 minutes on a clean bench. After plate plating, inoculation and culture were performed. A 5 mm diameter *Coprinus pungens* mycelial block was inoculated at the center of each plate, sealed with sealing film, and placed in a 25°C incubator for complete dark static incubation. After 7 days of incubation, a portion of the plates was harvested for observation of mycelial growth; simultaneously, another portion of plates was prepared and incubated for 40 days to determine the symbiotic germination rate of the seeds. Each treatment group had 5 biological replicates (n=5).

[0052] like Figure 5 As shown, the experimental results indicate that 4-methoxybenzoyl glucoside has a significant promoting effect. After 7 days of cultivation, the colony diameter and area were measured using ImageJv1.54p software, and all hyphae were collected and weighed. Quantitative results showed that the average hyphal length of the blank control group was 42.3 mm, the average hyphal fresh weight was 1.42 mg, and the seed co-germination rate was 16.8% after 40 days. In contrast, the average hyphal length of the 1 μm concentration treatment group (optimal concentration group) reached 51.7 mm, the average hyphal fresh weight was 1.93 mg, and the seed co-germination rate was as high as 28.5% after 40 days. Calculations showed that compared with the blank control group, at the optimal concentration of 1 μm, the hyphal biomass increased by 35.9%, and the seed co-germination rate increased by 11.7%, with statistical analysis showing a highly significant difference (p<0.0001). The experiment also found that when the concentration was higher than 10 μm, the promoting effect slightly decreased, which further verified the scientific validity of the preferred concentration range defined in this invention.

[0053] Similarly, the same efficacy verification experiment was conducted on p-methoxybenzoic acid. First, p-methoxybenzoic acid crystals were accurately weighed, dissolved in DMSO, and then serially diluted. Concentration gradients of 0.001, 0.01, 0.1, 1, and 10 μm were set up, with a blank control group containing an equal amount of DMSO solvent. The procedures for cultivation, inoculation, and index determination were completely consistent with the aforementioned experiment on 4-methoxybenzoyl glucoside.

[0054] like Figure 5As shown, p-methoxybenzoic acid also exhibited a strong promoting effect. Experimental data showed that the average hyphal length in the blank control group was 42.5 mm, the fresh weight of the hyphae was 1.40 mg, and the seed co-germination rate was 16.4%. In the 0.1 μm concentration treatment group (optimal concentration group), the average hyphal length increased to 49.8 mm, the fresh weight of the hyphae reached 1.85 mg, and the seed co-germination rate increased to 26.6%. Compared with the blank control group, at the optimal concentration of 0.1 μm, p-methoxybenzoic acid increased hyphal biomass by 32.1% and seed co-germination rate by 10.2%, with highly significant differences (p < 0.0001). This result demonstrates the effectiveness of p-methoxybenzoic acid as a promoter and identifies its lower optimal concentration.

[0055] To further elucidate the mechanism by which the above-mentioned compounds promote symbiotic germination, particularly to verify their dual function as a carbon source utilized by fungi, a mechanism verification experiment was conducted. The first step was a time-conversion experiment of 4-methoxybenzoyl glucoside. In the experiment, a sterile aqueous solution of the compound with a final concentration of 20 μm was prepared, inoculated with *Coprinus sarcodactylis* hyphae, and statically cultured at 25°C in the dark. Samples were taken at the 3rd hour, 1st day, 3rd day, and 4th day of culture. After filtration through a 0.45 μm filter membrane, the samples were analyzed by high-performance liquid chromatography (HPLC).

[0056] like Figure 6 As shown, the time-series HPLC results clearly reveal the degradation process of the compound. After 3 hours of incubation, the degradation product p-methoxybenzoic acid was detected in the system. By day 1, a large amount of the secondary degradation product p-hydroxybenzoic acid (p-HBA) was generated in the system. By day 3, the initially added 4-methoxybenzoyl glucoside and the intermediate p-methoxybenzoic acid had been almost completely consumed. By day 4, p-HBA was also completely degraded by the fungus. This series of dynamic changes strongly demonstrates that the symbiotic fungus can decompose 4-methoxybenzoyl glucoside stepwise and utilize its degradation products, thus confirming the inference that this compound can serve as a fungal carbon source.

[0057] To definitively confirm that these degradation products entered the central metabolic pathway of the fungus, a deuterium-labeled isotope tracing experiment was performed. 5 mg of deuterium-labeled isotopes was used... 2 [H4]-p-hydroxybenzoic acid (an isotopic label of p-HBA) was dissolved in 300 mL of sterile water, and 6 g of pre-activated fungal hyphae were inoculated and cultured at 25°C in the dark for 24 hours. After culture, intracellular metabolites of the hyphae were extracted by ultrasonication using a methanol-acetonitrile (1:1, v / v) mixed solvent and detected by UPLC-QTOF-MS / MS. Figure 7As shown, the experimental results successfully detected deuterium-labeled intermediate metabolites, including 3,4-dihydroxybenzoic acid-d3 and 1,4-benzenediol-d4, within the mycelial cells. These substances are key intermediates in the degradation of p-HBA and their entry into the tricarboxylic acid cycle (TCA cycle). This result directly demonstrates that the degradation products of the phenolic acid compounds described in this invention ultimately enter the core pathway of fungal energy metabolism, providing energy for fungal growth. This fundamentally distinguishes them from traditional signaling molecules that only have recognition functions, fully confirming that the compounds of this invention possess both chemotactic induction and carbon source nutrient supply functions, revealing the deep biological mechanism by which they efficiently promote symbiotic germination.

[0058] Furthermore, to verify the feasibility of the fungal propagation method proposed in this invention, namely, using the phenolic acid compound as an exogenous carbon source for fungal proliferation, the following experiments were conducted. A basic liquid culture medium without conventional carbon sources (such as sucrose) was prepared. Experimental groups and control groups were set up: Experimental group 1 had 4-methoxybenzoyl glucoside added to the basic liquid culture medium to a final concentration of 1 μm; Experimental group 2 had p-methoxybenzoic acid added to the basic liquid culture medium to a final concentration of 0.1 μm; the control group did not add any exogenous carbon source. Mycelial blocks of the same size were inoculated into each group's culture medium and placed in a shaker, cultured at 25°C, 120 rpm, and in the dark for 14 days. After cultivation, the mycelia of each group were collected and dried to constant weight, and their dry weight was measured. The results showed that, compared with the control group which showed almost no biomass growth, the dry weight of the mycelia in experimental groups 1 and 2 was significantly increased. The results confirm that both phenolic acid compounds described in this invention can be used as effective carbon sources by symbiotic fungi, supporting their growth and biomass accumulation under liquid culture conditions, thus proving that the in vitro expansion culture method proposed in this invention is effective and feasible.

Claims

1. Use of an alkoxy-substituted phenyl compound, characterized in that, The compound is selected from: Compounds having the structure shown in Formula I or an agriculturally acceptable salt thereof, wherein Formula I is Ar-CO-O-R2, Ar is a phenyl substituted with one or more C1-C4 alkoxy groups, and R2 is a monosaccharide residue; And compounds having the structure shown in Formula II or agriculturally acceptable salts thereof, wherein Formula II is Ar-COOH, and Ar is a phenyl substituted with one or more C1-C4 alkoxy groups.

2. The application according to claim 1, characterized in that, The compound is 4-methoxybenzoyl glucoside.

3. The application according to claim 1, characterized in that, The compound is p-methoxybenzoic acid.

4. The application according to claim 1, characterized in that, The symbiotic fungi are selected from one or more of the following: Coprinus spp., Coptis spp., and Rhizoctonia spp.

5. The application according to claim 1, characterized in that, The medicinal orchid plants are selected from one or more of the following: Rhododendron, Ginseng, Bletilla striata, Dendrobium, and Jade Phoenix Flower.

6. A method for promoting the symbiotic germination of seeds of medicinal orchid plants, characterized in that, Including the following steps: No later than inoculation of the symbiotic fungus, one or more compounds are applied to a culture system comprising the orchid seeds and the symbiotic fungus; The one or more compounds are selected from: compounds having the structure shown in Formula I or agriculturally acceptable salts thereof, wherein Formula I is Ar-CO-O-R2, Ar is a phenyl group substituted with one or more C1-C4 alkoxy groups, and R2 is a monosaccharide residue; and compounds having the structure shown in Formula II or agriculturally acceptable salts thereof, wherein Formula II is Ar-COOH, Ar is a phenyl group substituted with one or more C1-C4 alkoxy groups.

7. The method according to claim 6, characterized in that, The final concentration of the compound in the culture system is 0.001~10 μm.

8. The method according to claim 7, characterized in that, The compound is 4-methoxybenzoyl glucoside with a final concentration of 1 μm; or, the compound is p-methoxybenzoic acid with a final concentration of 0.1 μm.

9. The method according to claim 6, characterized in that, The application steps specifically include: before sowing the orchid seeds and inoculating the symbiotic fungi, adding the compound in advance and dissolving it evenly in the culture medium constituting the culture system.

10. A method for fungal propagation, characterized in that, This includes the step of culturing orchid symbiotic fungi in a liquid culture medium supplemented with compounds as exogenous carbon sources; The compounds are selected from: Compounds having the structure shown in Formula I or an agriculturally acceptable salt thereof, wherein Formula I is Ar-CO-O-R2, Ar is a phenyl substituted with one or more C1-C4 alkoxy groups, and R2 is a monosaccharide residue; And compounds having the structure shown in Formula II or agriculturally acceptable salts thereof, wherein Formula II is Ar-COOH and Ar is a phenyl substituted with one or more C1-C4 alkoxy groups; The final concentration of the compound in the liquid culture medium is 0.001~10 μm.